Literature DB >> 15150440

Microsatellite instability and its correlation with clinicopathological features in a series of thyroid tumors prevalent in iodine deficient areas.

Minal Vaish1, Anjali Mishra, Manish Kaushal, Saroj K Mishra, Balraj Mittal.   

Abstract

Thyroid tumors display diverse spectrum of histopathological groups with geographic variation in its prevalence. Influence of iodine deficiency (a major causative factor) in its etiology, prevalence, or aggressiveness is debatable which reflects the existence of various genetic events in pathogenesis. The present study was undertaken to study the role of Microsatellite instability (MSI) or LOH (loss of heterozygosity), an indicator of defective mismatch repair system as a genetic change and to explore it as a prognostic marker in thyroid tumors. Tumor tissues from total thyroidectomy surgical specimens and blood (matched control) of 36 patients from iodine deficient areas (10 benign; 26 malignant) were obtained after their consent. Urinary iodine analysis was done by alkali ash method for which 10 ml of urine was collected from 18 patients before surgery. Genomic DNA, isolated from tumor tissue and blood was amplified by polymerase chain reaction (PCR) using mono and dinucleotide markers - BAT-26, BAT-40, TGF(RII, IGFIIR, hMSH3, BAX, D2S123, D9S283, D9S851 and D18S58. PCR products were analysed on 8% denaturing polyacrylamide gel followed by autoradiography. Of total, 66.6% of tumors [70% (7/10) benign and 65.4% malignant cases (17/26)] showed MSI/LOH. Strong association of MSI/LOH with low iodine (P = 0.01) and with AMES risk groups i.e. age (P = 0.02), tumor size (P = 0.04) and metastases (P = 0.002) in thyroid tumors was observed. This may help in predicting the biological behaviour and strengthening the hypothesis that iodine deficiency has influence on MSI in thyroid tumors. Our results further substantiate the risk group classification and help in deciding the treatment modality in particular patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150440     DOI: 10.1038/emm.2004.18

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  6 in total

1.  Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.

Authors:  Luke K Genutis; Jerneja Tomsic; Ralf A Bundschuh; Pamela L Brock; Michelle D Williams; Sameek Roychowdhury; Julie W Reeser; Wendy L Frankel; Mohammed Alsomali; Mark J Routbort; Russell R Broaddus; Paul E Wakely; John E Phay; Christopher J Walker; Albert de la Chapelle
Journal:  Thyroid       Date:  2019-03-27       Impact factor: 6.568

2.  Large proportion of low frequency microsatellite-instability and loss of heterozygosity in pheochromocytoma and endocrine tumors detected with an extended marker panel.

Authors:  Susan Kupka; Birgit Haack; Marty Zdichavsky; Tanja Mlinar; Christine Kienzle; Thomas Bock; Reinhard Kandolf; Stefan-Martin Kroeber; Alfred Königsrainer
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-08       Impact factor: 4.553

3.  Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study.

Authors:  Constantinos Giaginis; Christina Michailidi; Vasileios Stolakis; Paraskevi Alexandrou; Gerasimos Tsourouflis; Jerzy Klijanienko; Ioanna Delladetsima; Stamatios Theocharis
Journal:  Med Sci Monit       Date:  2011-02-25

4.  Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.

Authors:  Juliana Carvalho Santos; André Uchimura Bastos; Janete Maria Cerutti; Marcelo Lima Ribeiro
Journal:  BMC Cancer       Date:  2013-02-15       Impact factor: 4.430

5.  Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.

Authors:  M L Read; J C Fong; B Modasia; A Fletcher; W Imruetaicharoenchoke; R J Thompson; H Nieto; J J Reynolds; A Bacon; U Mallick; A Hackshaw; J C Watkinson; K Boelaert; A S Turnell; V E Smith; C J McCabe
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

6.  Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.

Authors:  Monika Migdalska-Sęk; Karolina H Czarnecka; Michał Kusiński; Dorota Pastuszak-Lewandoska; Ewa Nawrot; Krzysztof Kuzdak; Ewa Brzeziańska-Lasota
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.